Medigen Vaccine Biologics (ROCO:6547) Cyclically Adjusted Book per Share: NT$11.42 (As of Dec. 2025)


ROCO:6547 Medigen Vaccine Biologics Corp ROCO:6547
66 GF Score
Price NT$47.40
GF Value NT$70.54
Valuation Possible Value Trap
! 2 Warning Signs
View Full Analysis

What is Medigen Vaccine Biologics Cyclically Adjusted Book per Share?

Medigen Vaccine Biologics ROCO:6547 66 Cyclically Adjusted Book per Share is NT$11.42 as of Dec. 2025. GuruFocus rates ROCO:6547 with a GF Score™ of 66/100 and a GF Value™ of NT$70.54 (Possible Value Trap). The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Medigen Vaccine Biologics's adjusted book value per share for the three months ended in Dec. 2025 was NT$10.583. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is NT$11.42 for the trailing ten years ended in Dec. 2025.

During the past 12 months, Medigen Vaccine Biologics's average Cyclically Adjusted Book Growth Rate was 8.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2026-07-12), Medigen Vaccine Biologics's current stock price is NT$47.40. Medigen Vaccine Biologics's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2025 was NT$11.42. Medigen Vaccine Biologics's Cyclically Adjusted PB Ratio of today is 4.15.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Medigen Vaccine Biologics was 5.23. The lowest was 3.10. And the median was 3.92.


Medigen Vaccine Biologics  (ROCO:6547) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Medigen Vaccine Biologics's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=47.40/11.42
=4.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Medigen Vaccine Biologics was 5.23. The lowest was 3.10. And the median was 3.92.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Medigen Vaccine Biologics Cyclically Adjusted Book per Share Related Terms


Medigen Vaccine Biologics Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Medigen Vaccine Biologics's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medigen Vaccine Biologics Cyclically Adjusted Book per Share Chart

Medigen Vaccine Biologics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 10.52 11.42

Medigen Vaccine Biologics Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.52 10.94 11.23 11.37 11.42

ROCO:6547 vs VRTX, REGN, ALNY: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, Medigen Vaccine Biologics's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medigen Vaccine Biologics Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Medigen Vaccine Biologics's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Medigen Vaccine Biologics's Cyclically Adjusted PB Ratio falls into.


ROCO:6547
66GF Score
Medigen Vaccine Biologics Corp ROCO:6547
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medigen Vaccine Biologics Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Medigen Vaccine Biologics's adjusted Book Value per Share data for the three months ended in Dec. 2025 was:

Adj_Book= Book Value per Share /CPI of Dec. 2025 (Change)*Current CPI (Dec. 2025)
=10.583/324.0540*324.0540
=10.583

Current CPI (Dec. 2025) = 324.0540.

Medigen Vaccine Biologics Quarterly Data

Book Value per Share CPI Adj_Book
201512 7.778 236.525 10.656
201606 7.295 241.018 9.808
201609 0.000 241.428 0.000
201612 7.754 241.432 10.408
201703 0.000 243.801 0.000
201706 7.187 244.955 9.508
201709 7.765 246.819 10.195
201712 7.256 246.524 9.538
201803 6.838 249.554 8.879
201806 7.829 251.989 10.068
201809 7.442 252.439 9.553
201812 6.765 251.233 8.726
201903 6.226 254.202 7.937
201906 5.575 256.143 7.053
201909 5.065 256.759 6.393
201912 5.766 256.974 7.271
202003 6.011 258.115 7.547
202006 5.411 257.797 6.802
202009 4.943 260.280 6.154
202012 9.999 260.474 12.440
202103 9.610 264.877 11.757
202106 9.084 271.696 10.835
202109 11.329 274.310 13.383
202112 14.759 278.802 17.155
202203 14.491 287.504 16.333
202206 18.522 296.311 20.256
202209 17.523 296.808 19.132
202212 15.340 296.797 16.749
202303 14.678 301.836 15.758
202306 13.696 305.109 14.546
202309 13.444 307.789 14.154
202312 11.706 306.746 12.367
202403 11.487 312.332 11.918
202406 11.702 314.175 12.070
202409 11.740 315.301 12.066
202412 11.712 315.605 12.026
202503 11.470 319.799 11.623
202506 11.151 322.561 11.203
202509 10.973 324.800 10.948
202512 10.583 324.054 10.583

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of NT$11.42 mean?
Medigen Vaccine Biologics (ROCO:6547) has a Cyclically Adjusted Book per Share of NT$11.42 as of Dec. 2025. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Medigen Vaccine Biologics and its competitors.
Is Medigen Vaccine Biologics' Cyclically Adjusted Book per Share too high?
Medigen Vaccine Biologics' current Cyclically Adjusted Book per Share is NT$11.42. Overall, Medigen Vaccine Biologics has a GF Score™ of 66/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Medigen Vaccine Biologics' Cyclically Adjusted Book per Share compare to VRTX and REGN?
Medigen Vaccine Biologics' Cyclically Adjusted Book per Share of NT$11.42 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Medigen Vaccine Biologics and its competitors. Medigen Vaccine Biologics's current Cyclically Adjusted Book per Share is NT$11.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medigen Vaccine Biologics stock overvalued right now?
Based on GuruFocus' analysis, Medigen Vaccine Biologics (ROCO:6547) is currently considered Possible Value Trap. The stock's GF Value™ is NT$70.54, compared to a current price of NT$47.40 — trading 32.8% below its estimated fair value. The current Cyclically Adjusted Book per Share is NT$11.42. Medigen Vaccine Biologics' overall GF Score™ is 66/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Medigen Vaccine Biologics (ROCO:6547), the current Cyclically Adjusted Book per Share is NT$11.42 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medigen Vaccine Biologics (ROCO:6547) Overvalued in 2026?

Based on GuruFocus' analysis, Medigen Vaccine Biologics stock appears to be undervalued. The current stock price of NT$47.40 is trading 32.8% below its estimated GF Value™ of NT$70.54. GuruFocus considers Medigen Vaccine Biologics to be Possible Value Trap.

Key valuation signals for ROCO:6547:

  • Cyclically Adjusted Book per Share: NT$11.42
  • GF Value™: NT$70.54 vs. price of NT$47.40 (32.8% below fair value)
  • GF Score™: 66/100 with 2 warning signs

No single metric tells the full story. See the ROCO:6547 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medigen Vaccine Biologics Business Description

Address 302 No. 68, Shengyi 3rd Road, Hsinchu County, Zhubei, TWN, 30261
Medigen Vaccine Biologics Corp is engaged in the research, development and wholesale of vaccine and biopharmaceutical, medical devices wholesale and retail, etc. Its products include dengue vaccine, anti-RSV biosimilars, COVID-19 vaccines, enterovirus A71 vaccine, and influenza vaccine QIZ. It operates business only in a single industry in Taiwan.
66GF Score

Get the complete analysis for ROCO:6547

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$47.40
Price
NT$70.54
GF Value